1.
Minerva Cardioangiol
; 60(6): 637-42, 2012 Dec.
Article
in English
| MEDLINE
| ID: mdl-23147440
ABSTRACT
Hypertrophic cardiomyopathy (HCM) occurs in 1 in every 500 individuals. It represents the most common cause of sudden cardiac death in those under the age of twenty-five. 3-5% patients with HCM go on to develop the dilated, hypokinetic end stage (ES) HCM with systolic failure. They have a higher incidence of heart failure, sudden deaths and defibrillator shocks. To the best of our knowledge this is first report of successful use of dronedarone for suppression of VT associated with ES HCM.
Subject(s)
Amiodarone/analogs & derivatives , Cardiomyopathy, Hypertrophic/complications , Tachycardia, Ventricular/drug therapy , Tachycardia, Ventricular/etiology , Adult , Amiodarone/therapeutic use , Dronedarone , Humans , Male
2.
Heart
; 95(6): 460, 2009 Mar.
Article
in English
| MEDLINE
| ID: mdl-19252007
Subject(s)
Atrial Appendage/diagnostic imaging , Heart Diseases/diagnostic imaging , Thrombosis/diagnostic imaging , Atrial Fibrillation/surgery , Catheter Ablation , Echocardiography, Transesophageal , False Negative Reactions , Humans , Male , Middle Aged , Preoperative Care/methods , Tomography, X-Ray Computed/methods
3.
Heart
; 94(10): 1287, 2008 Oct.
Article
in English
| MEDLINE
| ID: mdl-18801788